JP2000014356A - Production of gaba-containing beverage and food product - Google Patents

Production of gaba-containing beverage and food product

Info

Publication number
JP2000014356A
JP2000014356A JP11483199A JP11483199A JP2000014356A JP 2000014356 A JP2000014356 A JP 2000014356A JP 11483199 A JP11483199 A JP 11483199A JP 11483199 A JP11483199 A JP 11483199A JP 2000014356 A JP2000014356 A JP 2000014356A
Authority
JP
Japan
Prior art keywords
glutamic acid
producing
acid
gaba
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11483199A
Other languages
Japanese (ja)
Other versions
JP3172150B2 (en
Inventor
Hiroshi Misawa
宏 三沢
Kazuhito Hayakawa
和仁 早川
Keiko Kasaba
恵子 笠羽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26453494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2000014356(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Priority to JP11483199A priority Critical patent/JP3172150B2/en
Publication of JP2000014356A publication Critical patent/JP2000014356A/en
Application granted granted Critical
Publication of JP3172150B2 publication Critical patent/JP3172150B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Non-Alcoholic Beverages (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain beverage or food products in a low cost, containing γ- aminobutyric acid useful for improving hypertension and the like with excellent taste and color tone by inoculating a microorganism capable of producing protease to a specific food material and culturing it. SOLUTION: A food material that contains the peptide or protein including glutamic acid as a constituent amino acid, for example, powdered skim milk, soybean milk and the like is inoculated with a microorganism capable of producing protease, for example, a lactic acid bacterium that can liberate >=0.5 wt.% of glutamic acid after subtraction of its assimilated fraction based on the protein, when it is cultured in a 20% powdered skim milk substrate at 25-40 deg.C for 2 days and with a microorganism capable of producing glutamate decarboxylase, for example, a bacterium in Bifidobacterium, capable of producing >=600 mg/100 ml of γ-aminobutyric acid, when it is cultured in a culture medium containing 1,000 mg/100 ml of glutamic acid (glutamate salt) at 25-40 deg.C whereby the objective γ-aminobutyric acid-containing beverage or food products are obtained.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、γ−アミノ酪酸
(GABA)を含有する飲食品の製造法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a food or drink containing γ-aminobutyric acid (GABA).

【0002】[0002]

【従来の技術】哺乳類においては、GABAは、脳や脊
髄に存在する抑制性の神経伝達物質であり、その生理効
果については、脳の血流を活発にさせ、酸素供給量を増
大させて脳の代謝機能を亢進する、脊髄の血管運動中枢
に作用して血圧を降下させる、抗利尿ホルモンであるバ
ソプレッシンの分泌を抑制して、血管を拡張して血圧を
下げる、TCAサイクルの導入部に必要なヘキソキナー
ゼ活性を高め、糖代謝を促進させることに関与すること
など(新編脳代謝賦活剤、大友英一編、医薬ジャーナル
社(1987))が報告され、脳代謝賦活を目的に医薬
品としても利用されている。
2. Description of the Related Art In mammals, GABA is an inhibitory neurotransmitter present in the brain and spinal cord. Its physiological effect is to increase brain blood flow and increase oxygen supply to the brain. Increases the metabolic function of blood, lowers blood pressure by acting on the vasomotor center of the spinal cord, suppresses the secretion of vasopressin, an antidiuretic hormone, dilates blood vessels and lowers blood pressure, necessary for the introduction of TCA cycle Involved in enhancing the activity of hexokinase and promoting glucose metabolism (New Brain Metabolism Activator, Eiichi Otomo, Pharmaceutical Journal (1987)), and used as a drug for the purpose of activating brain metabolism Have been.

【0003】したがって、GABAを食品として摂取す
ることにより高血圧症の改善が期待できることから、適
当な処理を食品に施すことにより、GABA含有量を増
強させた食品もいくつか提唱されている。例えば、GA
BA富化コメ胚芽(オリザ油化(株))(コメ胚芽を嫌
気処理してGABA含量を0.3%に高めた食品);ギ
ャバロン茶(多社)(茶葉を嫌気処理してGABA含量
を処理前の数十倍の220mg%に高めた茶)等が知られ
ている。
[0003] Therefore, since hypertension can be expected to be improved by ingesting GABA as a food, some foods in which the GABA content is enhanced by applying appropriate treatment to the food have been proposed. For example, GA
BA-enriched rice germ (Oriza Yuka Co., Ltd.) (food that germ-treated rice germ to increase GABA content to 0.3%); GABARON tea (many companies) (tea leaves are anaerobically treated to reduce GABA content) Tea), which is several tens of times higher than that before treatment, and is increased to 220 mg%, etc., are known.

【0004】一方、微生物を利用してGABAを富化し
た食品の製造方法として、牛乳にグルタミン酸(塩)を
添加し、GABAを生成する能力を持つ乳酸菌を接種し
培養してGABAを含有する発酵食品を得る方法(特開
平7−227245号)、またグルタミン酸(ナトリウ
ム)に酵母又はクロレラの細胞破砕液を作用させてGA
BAを富化した食品素材を製造する方法(特開平9−2
38850号)などがある。
On the other hand, as a method for producing GABA-enriched foods using microorganisms, glutamic acid (salt) is added to milk, lactic acid bacteria capable of producing GABA are inoculated and cultured, and fermentation containing GABA is performed. A method for obtaining food (Japanese Patent Application Laid-Open No. 7-227245), and a method in which yeast or chlorella cell lysate is allowed to act on glutamic acid (sodium).
Method for producing food material enriched in BA
No. 38850).

【0005】[0005]

【発明が解決しようとする課題】しかしながら、従来の
微生物を利用したGABA含有飲食品の製造法において
は、いずれもグルタミン酸又はその塩を添加しており、
食品の味を変化させてしまう、殺菌時などに熱が加わる
とグルタミン酸と還元糖(糖質)がアミノカルボニル反
応を起こし変色してしまう、作業性が悪く製造コストも
高くなってしまう等の問題があった。従って、本発明の
目的は味及び色調が良好なGABA含有飲食品の製造法
を提供することにある。
However, in conventional methods for producing GABA-containing foods and drinks using microorganisms, glutamic acid or a salt thereof is added,
Problems such as altering the taste of foods, glutamate and reducing sugars (sugars) causing aminocarbonyl reaction and discoloring when heat is applied during sterilization, etc., resulting in poor workability and high manufacturing costs was there. Accordingly, an object of the present invention is to provide a method for producing a GABA-containing food or drink having good taste and color tone.

【0006】[0006]

【課題を解決するための手段】そこで本発明者らは、上
記課題を解決すべく種々検討した結果、食品素材として
グルタミン酸を構成アミノ酸として含む蛋白質又はペプ
チドを含有するものを用い、これにプロテアーゼ生産能
を有する微生物とグルタミン酸デカルボキシラーゼ生産
能を有する微生物とを接種して培養すれば、GABAを
豊富に含有し、かつ味を損なわず、色調の良好な飲食品
が得られることを見出し、本発明を完成した。
The inventors of the present invention have conducted various studies to solve the above-mentioned problems. As a result, the present inventors have used a food material containing a protein or peptide containing glutamic acid as a constituent amino acid, and produced a protease using the same. It has been found that, by inoculating and culturing a microorganism having an ability to produce glutamic acid decarboxylase and a microorganism having an ability to produce glutamate decarboxylase, foods and drinks having a good color tone can be obtained, which contain GABA abundantly and do not impair the taste. Was completed.

【0007】すなわち、本発明は、グルタミン酸を構成
アミノ酸として含む蛋白質又はペプチドを含有する食品
素材に、プロテアーゼ生産能を有する微生物及びグルタ
ミン酸デカルボキシラーゼ生産能を有する微生物を接種
して培養することを特徴とするGABA含有飲食品の製
造法及びかくして得られる飲食品を提供するものであ
る。
That is, the present invention is characterized in that a food material containing a protein or a peptide containing glutamic acid as a constituent amino acid is inoculated with a microorganism having a protease-producing ability and a microorganism having a glutamic acid decarboxylase-producing ability and cultured. The present invention also provides a method for producing GABA-containing food and drink, and a food and drink thus obtained.

【0008】[0008]

【発明の実施の形態】本発明飲食品の素材は、グルタミ
ン酸を構成アミノ酸として含む蛋白質又はペプチドを含
有するものである。多くの食品素材中の蛋白質は、グル
タミン酸を構成アミノ酸として含むので、食品素材は蛋
白質を含むものであれば特に制限されない。例えば、肉
類、魚介類、乳類が挙げられるが、カゼインタンパクに
は約20%ものグルタミン酸が含まれており、大豆タン
パク質にも豊富にグルタミン酸が含まれているので、獣
乳、大豆又はそれらの加工品、例えば脱脂粉乳、豆乳等
が好ましい。
BEST MODE FOR CARRYING OUT THE INVENTION The food or drink material of the present invention contains a protein or peptide containing glutamic acid as a constituent amino acid. Since proteins in many food materials contain glutamic acid as a constituent amino acid, the food materials are not particularly limited as long as they contain proteins. For example, meat, seafood, and milk can be mentioned. Casein protein contains about 20% of glutamic acid, and soy protein contains abundant glutamic acid. Processed products such as skim milk powder and soy milk are preferred.

【0009】プロテアーゼ生産能を有する微生物として
は、食品に添加することができるプロテアーゼ生産菌で
あれば特に制限されないが、20%脱脂粉乳を基質とし
て25〜40℃で2日間培養したとき、グルタミン酸を
資化する分を差し引いて、少なくともタンパク質に対し
て0.5重量%以上、特に0.7重量%以上のグルタミ
ン酸を遊離するものが好ましい。中でもグルタミン酸遊
離活性が高いのみならず、グルタミン酸要求性、すなわ
ち、遊離のグルタミン酸を資化しGABA産生以外に用
いてしまう活性の低いものが好ましい。より具体的には
ラクトバチルス(Lactobacillus)属、ラ
クトコッカス(Lactococcus)属、ビフィド
バクテリウム(Bifidobacterium)属等
の細菌が挙げられる。この中でラクトバチルス・カゼイ
(Lactobacilluscasei(以下L.カ
ゼイ))、ラクトコッカス・ラクチス(Lactoco
ccus lactis(以下L.ラクチス))、ラク
トコッカス・ラクチスサブスピーシーズ.クレモリス
(Lactococcus lactis ss.cr
emoris(以下L.クレモリス))が好ましく、具
体的にはL.カゼイ YIT 9029(FERM B
P−1366)、L.ラクチス YIT2027(FE
RM BP−6224)及びL.クレモリス YIT
2007(ATCC19257)が挙げられる。
The microorganism having protease-producing ability is not particularly limited as long as it is a protease-producing bacterium that can be added to foods. When cultured at 25 to 40 ° C. for 2 days using 20% nonfat dry milk as a substrate, glutamic acid is converted to It is preferable that the glutamate release at least 0.5% by weight or more, especially 0.7% by weight or more based on the protein after subtracting the amount of assimilation. Among them, those having not only high glutamic acid releasing activity but also low glutamic acid requirement, that is, low activity of assimilating free glutamic acid and using it for purposes other than GABA production are preferable. More specifically, bacteria such as Lactobacillus, Lactococcus, Bifidobacterium, and the like can be mentioned. Among these, Lactobacillus casei (hereinafter referred to as L. casei), Lactococcus lactis (Lactoco
ccus lactis (hereinafter referred to as L. lactis)), Lactococcus lactis subspecies. Cremoris (Lactococcus lactis ss. Cr
emoris (hereinafter referred to as L. cremolis)), and specifically L. cremoris. Casei YIT 9029 (FERM B
P-1366); Lactis YIT2027 (FE
RM BP-6224) and L.P. Cremoris YIT
2007 (ATCC 19257).

【0010】グルタミン酸デカルボキシラーゼ生産能を
有する微生物としては、食品に添加することができるグ
ルタミン酸デカルボキシラーゼ生産菌であれば特に制限
されないが、グルタミン酸又はその塩を1000mg/1
00mL添加した培地において25〜40℃で培養したと
き、GABAを600mg/100mL以上、特に800mg
/100mL以上産生する能力を持つものが好ましい。こ
の微生物も上記と同様にグルタミン酸要求性の低いもの
が特に好ましい。また、食品素材として乳類を用いる場
合には、グルタミン酸デカルボキシラーゼ生産性の乳酸
菌又はビフィドバクテリウム属細菌が好ましい。より具
体的にはラクトバチルス属、ラクトコッカス属、ビフィ
ドバクテリウム属等の細菌が挙げられる。この中でラク
トコッカス ラクチスが好ましい。具体的にはYIT
2027が挙げられる。
The microorganism having the ability to produce glutamic acid decarboxylase is not particularly limited as long as it is a glutamic acid decarboxylase-producing bacterium that can be added to foods.
When cultured at 25 to 40 ° C. in a medium supplemented with 00 mL, GABA is 600 mg / 100 mL or more, particularly 800 mg.
/ 100 mL or more is preferable. It is particularly preferable that this microorganism has a low glutamic acid requirement similarly to the above. When milk is used as a food material, a lactic acid bacterium or a bacterium belonging to the genus Bifidobacterium that produces glutamate decarboxylase is preferable. More specifically, bacteria such as Lactobacillus, Lactococcus, Bifidobacterium and the like can be mentioned. Among them, Lactococcus lactis is preferred. Specifically, YIT
2027.

【0011】前記食品素材に上記2種を接種して培養す
るには、接種した微生物に適した条件を選択すればよ
い。また、上記2種の微生物を同時に接種して培養して
もよいが、まずプロテアーゼ生産菌を接種して培養し、
次いでグルタミン酸デカルボキシラーゼ生産菌を接種し
て培養してもよい。また、プロテアーゼ及びグルタミン
酸デカルボキシラーゼの両者を生産する微生物、例えば
L.ラクチス YIT2027を用いれば、用いる微生
物は1種でよいが、GABA生産能等から、2株以上を
混合培養する方が好ましい。なお、両方の酵素を有する
微生物の中には、遊離したグルタミン酸を、すぐにGA
BAへと変換するものもあるため、この場合プロテアー
ゼ活性は見かけ上低くなってしまうことに留意すべきで
ある。
[0011] In order to inoculate the above-mentioned food materials with the above two species and culture them, conditions suitable for the inoculated microorganisms may be selected. Alternatively, the above two microorganisms may be inoculated and cultured at the same time.
Then, a glutamic acid decarboxylase-producing bacterium may be inoculated and cultured. Also, microorganisms that produce both protease and glutamate decarboxylase, such as L. If Lactis YIT2027 is used, only one kind of microorganism may be used, but it is more preferable to mix and culture two or more strains from the viewpoint of GABA production ability and the like. In some microorganisms having both enzymes, the released glutamic acid was immediately replaced with GA.
It should be noted that in this case the protease activity is apparently lower, since some convert to BA.

【0012】また、乳類を含有する食品素材に、プロテ
アーゼ生産能を有する乳酸菌又はビフィドバクテリウム
属細菌とグルタミン酸デカルボキシラーゼ生産能を有す
る乳酸菌又はビフィドバクテリウム属細菌とを同時ある
いは順次接種して培養する際にも、用いる菌の増殖や酵
素生産等に好適な条件を設定すればよい。一般には、3
0〜37℃で、2日〜1週間程度培養すればよく、乳濃
度としては、無脂乳固形分換算で8重量%以上、特に8
〜30重量%程度が、GABA生産能、乳の溶解性等の
作業性、コスト面等から好ましい。このようにして得ら
れた食品はGABAを含有する発酵乳飲食品である。こ
の発酵乳飲食品中にはカゼイン分解ペプチドが含まれて
おり、GABAだけでなく当該カゼイン分解ペプチドも
血圧効果作用を含めた種々の生理活性を有することが知
られており、特に好ましい。
A lactic acid bacterium or Bifidobacterium belonging to a protease-producing ability and a lactic acid bacterium or Bifidobacterium belonging to a glutamic acid decarboxylase-producing ability are simultaneously or sequentially inoculated into a food material containing milk. When culturing the cells, conditions suitable for the growth of the bacteria to be used, the production of enzymes, and the like may be set. Generally, 3
The culture may be performed at 0 to 37 ° C. for about 2 days to 1 week, and the milk concentration is 8% by weight or more, especially 8% by weight in terms of non-fat milk solids.
About 30% by weight is preferable in terms of GABA productivity, workability such as solubility of milk, and cost. The food thus obtained is a fermented milk food and drink containing GABA. This fermented milk food and drink contains a casein-degrading peptide, and it is known that not only GABA but also the casein-degrading peptide has various physiological activities including a blood pressure effect, and is particularly preferable.

【0013】本発明は食品素材に含まれる蛋白質又はペ
プチドからプロテアーゼ生産菌の作用によりグルタミン
酸を遊離させ、遊離したグルタミン酸をグルタミン酸デ
カルボキシラーゼ生産菌の作用によりGABAに変換さ
せるものである。このように2種の微生物を使用するこ
とにより、食品添加物であるグルタミン酸を添加する必
要がないため、味、色調が変化せず、GABA含量が高
い飲食品が安価に得られる。
According to the present invention, glutamic acid is released from a protein or peptide contained in a food material by the action of a protease-producing bacterium, and the released glutamic acid is converted into GABA by the action of a glutamic acid decarboxylase-producing bacterium. By using two kinds of microorganisms in this way, it is not necessary to add glutamic acid as a food additive, so that foods and drinks having a high GABA content without changing taste and color tone can be obtained at low cost.

【0014】得られる飲食品としては発酵乳食品、発酵
豆乳食品、漬物、納豆、酒類等が挙げられる。
The foods and drinks obtained include fermented milk foods, fermented soy milk foods, pickles, natto, liquors and the like.

【0015】[0015]

【実施例】次に実施例を挙げて本発明を詳細に説明する
が、本発明は何らこれに限定されるものではない。
Next, the present invention will be described in detail with reference to examples, but the present invention is not limited to these examples.

【0016】参考例1 プロテアーゼ生産能を有する微
生物の選択 脱脂粉乳の約34%はタンパク質で、そのうちグルタミ
ン酸が約20%と高い。従って、脱脂粉乳溶液の発酵過
程でグルタミン酸を遊離させる活性の高い乳酸菌を選択
する。 材料と方法 使用菌株 表1に示した菌株を30℃あるいは37℃で2回継代し
て用いた。
Reference Example 1 Selection of Microorganism Having Protease-Producing Ability About 34% of skim milk powder is protein, of which glutamic acid is as high as about 20%. Therefore, a lactic acid bacterium having a high activity of releasing glutamic acid during the fermentation process of the skim milk solution is selected. Materials and Methods Strains Used The strains shown in Table 1 were used at 30 ° C. or 37 ° C. twice subcultured.

【0017】培養条件:20%脱脂粉乳溶液(121
℃、15分滅菌)で、30℃あるいは37℃で3日間培
養した。 測定方法:アミノ酸自動分析装置(JCL−300 日
本電子(株))及びデータ処理装置(LC30−DK1
0 日本電子(株))にてGABAとグルタミン酸の定
量を行った。アミノ酸の分離には強酸性陽イオン交換樹
脂(パックドカラム LCR−6:ポリスチレン樹脂に
スルホン酸基を導入したもの)を用い、定量はニンヒド
リン発色法を利用した。20%脱脂粉乳溶液中には、約
1000mg/100mL程度のグルタミン酸が含まれてお
り、培養前には10mg/100mL程度が遊離している。
このため、グルタミン酸遊離率は、以下の式で算出し
た。
Culture conditions: 20% skim milk solution (121
(Sterilized at 15 ° C. for 15 minutes) at 30 ° C. or 37 ° C. for 3 days. Measurement method: Amino acid automatic analyzer (JCL-300 JEOL Ltd.) and data processor (LC30-DK1)
0 JEOL Ltd.) to determine GABA and glutamic acid. For separation of amino acids, a strongly acidic cation exchange resin (packed column LCR-6: a polystyrene resin having a sulfonic acid group introduced) was used, and quantification was performed using a ninhydrin coloring method. The 20% skim milk solution contains about 1000 mg / 100 mL of glutamic acid, and about 10 mg / 100 mL is released before culture.
For this reason, the glutamate release rate was calculated by the following equation.

【0018】[0018]

【数1】 (Equation 1)

【0019】結果 グルタミン酸の遊離を表1にまた、その際のGABA濃
度を表2に示す。
Results Table 1 shows the release of glutamic acid, and Table 2 shows the GABA concentration at that time.

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【表2】 [Table 2]

【0022】グルタミン酸遊離活性は、30℃で培養し
たL.カゼイ YIT 9029が最も高く、3日間培
養で1.2重量%の遊離グルタミン酸が認められた。Y
IT9029はペプチド鎖のN−末端からアミノ酸を1
残基ずつ遊離するアミノペプチダーゼ活性が高くグルタ
ミン酸の要求量が小さいことが考えられた。L.クレモ
リス YIT 2007(ATCC 19257T)あ
るいはL.ヘルベティカス YIT 0083(ATC
C15009T)も、グルタミン酸遊離能が高かった。
一方、L.ラクチス YIT 2027とStrept
cuccus thermophilus(S.サーモ
フィルス)YIT 2001の培養においてはグルタミ
ン酸が認められないがこれは前者では遊離したグルタミ
ン酸がGABAに変換されたためで、後者においては同
化代謝されたものと考えられた。通常、1gのグルタミ
ン酸からは約0.7gのGABAが生産されることか
ら、YIT2027の実際のグルタミン酸遊離率は、培
養2日目において約7.14%と考えられる。以上の検
討結果より、ミルクタンパク質よりグルタミン酸を遊離
する株としてL.カゼイ YIT 9029及びL.ク
レモリス YIT 2007及びL.ラクチス YIT
2027が2日間培養したとき0.5重量%以上のグ
ルタミン酸を遊離するので好ましいものといえる。
Glutamate-releasing activity was determined by culturing at 30.degree. Casei YIT 9029 was the highest, and 1.2% by weight of free glutamic acid was observed after 3 days of culture. Y
IT9029 has one amino acid from the N-terminus of the peptide chain.
It was considered that the activity of aminopeptidase released by each residue was high and the required amount of glutamic acid was small. L. Cremoris YIT 2007 (ATCC 19257 T ) or L. Helveticas YIT 0083 (ATC
C15009 T ) also had high glutamate releasing ability.
On the other hand, L. Lactis YIT 2027 and Strept
Glutamic acid was not observed in the culture of C. cucus thermophilus (S. thermophilus) YIT 2001, but this was because the released glutamic acid was converted to GABA in the former, and it was considered that the latter was assimilated and metabolized. Since about 0.7 g of GABA is usually produced from 1 g of glutamic acid, the actual glutamic acid release rate of YIT2027 is considered to be about 7.14% on the second day of culture. From the above examination results, L. as a strain that releases glutamic acid from milk protein. Casei YIT 9029 and L. Cremoris YIT 2007 and L. Lactis YIT
2027 is preferable since it releases 0.5% by weight or more of glutamic acid when cultured for 2 days.

【0023】参考例2 表3に示す菌株を1000mg/100mLのグルタミン酸
ナトリウムを添加した20%脱脂粉乳溶液で30℃(Y
IT 2027のみ)あるいは37℃(他の菌株全て)
で3日間培養した。結果を表3に示す。グルタミン酸を
GABAに変換する株として、L.ラクチス YIT2
027が好ましいものといえる。
REFERENCE EXAMPLE 2 The strains shown in Table 3 were added to a 20% skim milk solution containing 1000 mg / 100 mL of sodium glutamate at 30 ° C. (Y
IT 2027 only) or 37 ° C (all other strains)
For 3 days. Table 3 shows the results. As a strain that converts glutamic acid to GABA, L. glutamic acid is used. Lactis YIT2
027 is preferable.

【0024】[0024]

【表3】 [Table 3]

【0025】実施例1 加熱殺菌した30%脱脂粉乳溶液に発酵乳由来のL.ラ
クチス YIT 2027(FERM BP−624
4)とチーズ由来のL.クレモリス YIT 2007
(ATCC 19257)を10対1の割合で接種し、
30℃で3日間培養した。GABAは、発酵前において
は確認されなかったが、発酵終了後には30mg/100
mLに増加していた。
Example 1 Heat-sterilized 30% skim milk solution was mixed with L. fermented milk. Lactis YIT 2027 (FERM BP-624
4) and cheese-derived L. Cremoris YIT 2007
(ATCC 19257) at a ratio of 10: 1,
The cells were cultured at 30 ° C. for 3 days. GABA was not confirmed before fermentation, but after the fermentation, 30 mg / 100
mL.

【0026】実施例2 加熱殺菌した乳糖を添加した豆乳に発酵乳由来のL.ラ
クチス YIT 2027とチーズ由来のL.クレモリ
ス YIT 2007を10対1の割合で接種し、30
℃で3日間培養した。GABAは、発酵前においては確
認されなかったが、発酵終了後には32mg/100mLに
増加していた。
Example 2 Lactose derived from fermented milk was added to soymilk to which heat-sterilized lactose was added. Lactis YIT 2027 and cheese-derived L. Inoculate Cremoris YIT 2007 at a ratio of 10: 1 and 30
C. for 3 days. GABA was not confirmed before fermentation, but increased to 32 mg / 100 mL after fermentation.

【0027】比較例1 30%脱脂粉乳溶液に終濃度15g/Lとなるようグル
タミン酸(Na)を添加し、これを100℃、30分加
熱殺菌した後L.lactis YIT 2027を接
種し、30℃で3日間培養した。発酵終了後のGABA
濃度は105mg/100mLであった。
Comparative Example 1 Glutamic acid (Na) was added to a 30% skim milk solution to a final concentration of 15 g / L, and the mixture was sterilized by heating at 100 ° C. for 30 minutes. lactis YIT 2027, and cultured at 30 ° C. for 3 days. GABA after fermentation
The concentration was 105 mg / 100 mL.

【0028】試験例1 実施例1及び比較例1で得られた発酵乳を用い、下記処
方のサンプルを調製した。これらの風味・色調を専門パ
ネラー5名で官能評価した。
Test Example 1 Using the fermented milk obtained in Example 1 and Comparative Example 1, a sample having the following formulation was prepared. These flavors and colors were sensory evaluated by five expert panelists.

【0029】[0029]

【表4】 (処方) 発酵乳 30(重量%) 30%ショ糖溶液 30 安定剤(ペクチン) 0.3 フレーバー 0.1 水 残量(Formulation) Fermented milk 30 (% by weight) 30% sucrose solution 30 Stabilizer (pectin) 0.3 Flavor 0.1 Water Remaining amount

【0030】風味評価はアミノ酸臭やコゲ臭等も含めた
指標として、+1:おいしい、0:普通、−1:まずい
とし、色調は、+1:色調がよい、0:やや色調が悪い
が気にならない、−1:色調が悪いとした。その結果、
本発明の発酵乳飲料は、グルタミン酸を添加したサンプ
ルよりも風味・色調ともに良好であった。比較例のサン
プルはややグルタミン酸風味が感じられた。
The flavor evaluation is an index including an amino acid smell and a burnt smell, and the like: +1: delicious, 0: normal, -1: unsatisfactory, color tone: +1: good color tone, 0: slightly poor color tone No, -1: poor color tone. as a result,
The fermented milk beverage of the present invention had better flavor and color tone than the sample to which glutamic acid was added. The sample of the comparative example had a slightly glutamic acid flavor.

【0031】[0031]

【表5】 [Table 5]

【0032】比較例2 実施例1と同一の培地に、グルタミン酸遊離活性の低い
S.サーモフィルスYIT 2001とグルタミン酸デ
カルボキシラーゼ活性の高いL.ラクチスYIT 20
27を1:1の割合で接種し、30℃で3日間培養し
た。GABAは、発酵前においては確認されなかった
が、発酵終了後には4mg/100mLに増加していた。
Comparative Example 2 In the same medium as in Example 1, S. cerevisiae having a low glutamate releasing activity was used. L. thermophilus YIT 2001 and L. glutamic acid decarboxylase with high activity. Lactis YIT 20
27 was inoculated at a ratio of 1: 1 and cultured at 30 ° C. for 3 days. GABA was not confirmed before fermentation, but increased to 4 mg / 100 mL after fermentation.

【0033】比較例3 実施例1と同一の培地に、グルタミン酸遊離活性の高い
L.カゼイ YIT2029とグルタミン酸デカルボキ
シラーゼ活性の低いラクトバチルス アシドフィルス
(Lactobacillus asidophilu
s)YIT 0168を1:1の割合で接種し、30℃
で3日間培養した。GABAは、発酵前においては確認
されなかったが、発酵終了後には0.5mg/100mLに
増加していた。
Comparative Example 3 In the same medium as in Example 1, L. cerevisiae having high glutamate releasing activity was added. Lactobacillus acidophilus with low activity of casei YIT2029 and glutamate decarboxylase
s) YIT 0168 was inoculated at a ratio of 1: 1 at 30 ° C.
For 3 days. GABA was not confirmed before fermentation, but increased to 0.5 mg / 100 mL after fermentation.

【0034】実施例3 ミルクタンパク質からグルタミン酸を遊離する活性の高
いL.カゼイ YIT9029とグルタミン酸からGA
BAに変換する活性の高いL.ラクチス YIT 20
27を単独及び混合培養した。加熱殺菌した30%脱脂
粉乳溶液に両菌株を1:1の割合で接種し、30℃で3
日間培養した。このときのGABA産生量の培養経時変
化を図1に示す。
Example 3 L. with high activity to release glutamic acid from milk protein GA from casei YIT9029 and glutamic acid
L. having high activity to convert to BA. Lactis YIT 20
27 were singly and mixedly cultured. Both strains were inoculated in a 30% non-fat dry milk solution heat-sterilized at a ratio of 1: 1.
Cultured for days. FIG. 1 shows the time course of GABA production at this time.

【0035】3日間の培養においてL.ラクチス YI
T 2027は単独でもGABA産生濃度が15mg/1
00mLに達した。また、L.カゼイ YIT 9029
と混合培養を行うことにより2倍以上の38mg/100
mLまで増加し、混合培養の有用性が確認された。このと
きのグルタミン酸濃度は1mg/100mLであった。
After 3 days of culture, L. Lactis YI
T 2027 alone has a GABA production concentration of 15 mg / 1
00 mL was reached. L. Casei YIT 9029
More than double 38mg / 100 by performing mixed culture with
It increased to mL, confirming the usefulness of mixed culture. The glutamic acid concentration at this time was 1 mg / 100 mL.

【0036】更に菌株の接種比率を指数的に変化させて
GABAの産生を検討した。その結果、L.カゼイ Y
IT 9029とL.ラクチス YIT2027の比が
1:1〜10:1でGABA濃度が高くなることがわか
った(表6)。
Further, GABA production was examined by changing the inoculation ratio of the strain exponentially. As a result, L. Casey Y
IT 9029 and L.E. It was found that the GABA concentration increased when the ratio of Lactis YIT2027 was 1: 1 to 10: 1 (Table 6).

【0037】[0037]

【表6】 [Table 6]

【0038】以上の検討結果から、L.カゼイ YIT
9029とL.ラクチス YIT2027を同時に
1:1の比率で接種し、培養することがGABA含量を
高める有効な方法であることが明らかとなった。
From the above examination results, L. Casei YIT
9029 and L.E. Inoculation and cultivation of Lactis YIT2027 simultaneously at a ratio of 1: 1 proved to be an effective method for increasing the GABA content.

【0039】参考例2 高血圧自然発症マウス(SHR)に発酵乳を投与したと
きの血圧変化 条件:14週令、オス、5匹/群、飼料に10%の本発
明の凍結乾燥発酵乳(実施例3において、両菌株を1:
1と接種し調整したもの)を混ぜて自由摂食させた。対
照群、発酵乳群ともに飼料には食塩を1%添加した。結
果を図2に示す。今回調製したGABA含有発酵乳を投
与することにより、血圧上昇を抑える傾向が認められ
た。投与21日目では、有意(p<0.05)に血圧上
昇を抑えていることがわかる。
Reference Example 2 Changes in blood pressure when fermented milk was administered to spontaneously hypertensive mice (SHR) Conditions: 14-week-old, male, 5 / group, 10% lyophilized fermented milk of the present invention (feed) In Example 3, both strains were:
1 and inoculated and adjusted) and allowed to eat freely. 1% of salt was added to the feed for both the control group and the fermented milk group. The results are shown in FIG. By administering the GABA-containing fermented milk prepared this time, a tendency to suppress the increase in blood pressure was observed. On the 21st day of administration, it can be seen that the increase in blood pressure was significantly (p <0.05) suppressed.

【0040】[0040]

【発明の効果】本発明によれば味、色調が良好なGAB
A含有飲食品が効率よく得られる。
According to the present invention, GAB having good taste and color tone
A-containing food and drink can be obtained efficiently.

【図面の簡単な説明】[Brief description of the drawings]

【図1】菌株1種と2種の場合のGABA濃度の経時変
化を示す図である。
BRIEF DESCRIPTION OF DRAWINGS FIG. 1 is a diagram showing a time-dependent change in GABA concentration for one strain and two strains.

【図2】高血圧自然発症マウスに本発明の発酵乳を投与
したときの血圧変化を示す図である。
FIG. 2 shows changes in blood pressure when the fermented milk of the present invention is administered to spontaneously hypertensive mice.

【手続補正書】[Procedure amendment]

【提出日】平成11年5月11日(1999.5.1
1)
[Submission date] May 11, 1999 (1999.5.1
1)

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0018[Correction target item name] 0018

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0018】[0018]

【数1】 (Equation 1)

【手続補正2】[Procedure amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0022[Correction target item name] 0022

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0022】グルタミン酸遊離活性は、30℃で培養し
たL.カゼイ YIT 9029が最も高く、3日間培
養で1.2重量%の遊離グルタミン酸が認められた。Y
IT9029はペプチド鎖のN−末端からアミノ酸を1
残基ずつ遊離するアミノペプチダーゼ活性が高くグルタ
ミン酸の要求量が小さいことが考えられた。L.クレモ
リス YIT 2007(ATCC 19257T)あ
るいはL.ヘルベティカス YIT 0083(ATC
C15009T)も、グルタミン酸遊離能が高かった。
一方、L.ラクチス YIT 2027とStrept
cuccus thermophilus(S.サーモ
フィルス)YIT 2001の培養においてはグルタミ
ン酸が認められないがこれは前者では遊離したグルタミ
ン酸がGABAに変換されたためで、後者においては同
化代謝されたものと考えられた。通常、1gのグルタミ
ン酸からは約0.7gのGABAが生産されることか
ら、YIT2027の実際のグルタミン酸遊離率は、培
養2日目において約0.714%と考えられる。以上の
検討結果より、ミルクタンパク質よりグルタミン酸を遊
離する株としてL.カゼイ YIT 9029及びL.
クレモリス YIT 2007及びL.ラクチス YI
T 2027が2日間培養したとき0.5重量%以上の
グルタミン酸を遊離するので好ましいものといえる。
Glutamate-releasing activity was determined by culturing at 30.degree. Casei YIT 9029 was the highest, and 1.2% by weight of free glutamic acid was observed after 3 days of culture. Y
IT9029 has one amino acid from the N-terminus of the peptide chain.
It was considered that the activity of aminopeptidase released by each residue was high and the required amount of glutamic acid was small. L. Cremoris YIT 2007 (ATCC 19257 T ) or L. Helveticas YIT 0083 (ATC
C15009 T ) also had high glutamate releasing ability.
On the other hand, L. Lactis YIT 2027 and Strept
Glutamic acid was not observed in the culture of C. cucus thermophilus (S. thermophilus) YIT 2001, but this was because the released glutamic acid was converted to GABA in the former, and it was considered that the latter was assimilated and metabolized. Since about 0.7 g of GABA is usually produced from 1 g of glutamic acid, the actual glutamic acid release rate of YIT2027 is considered to be about 0.714% on the second day of culture. From the above examination results, L. as a strain that releases glutamic acid from milk protein. Casei YIT 9029 and L.
Cremoris YIT 2007 and L. Lactis YI
T2027 is preferable because it releases 0.5% by weight or more of glutamic acid when cultured for 2 days.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) // A23B 7/10 A23L 2/00 F A23C 9/123 J ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) // A23B 7/10 A23L 2/00 F A23C 9/123 J

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 グルタミン酸を構成アミノ酸として含む
蛋白質又はペプチドを含有する食品素材に、プロテアー
ゼ生産能を有する微生物及びグルタミン酸デカルボキシ
ラーゼ生産能を有する微生物を接種して培養することを
特徴とするγ−アミノ酪酸含有飲食品の製造法。
1. A γ-amino acid characterized in that a food material containing a protein or a peptide containing glutamic acid as a constituent amino acid is inoculated with a microorganism having a protease-producing ability and a microorganism having a glutamic acid decarboxylase-producing ability and cultured. A method for producing butyric acid-containing food or drink.
【請求項2】 プロテアーゼ生産能を有する微生物及び
グルタミン酸デカルボキシラーゼ生産能を有する微生物
が、乳酸菌又はビフィドバクテリウム属細菌である請求
項1記載の製造法。
2. The method according to claim 1, wherein the microorganism capable of producing protease and the microorganism capable of producing glutamate decarboxylase are lactic acid bacteria or bacteria of the genus Bifidobacterium.
【請求項3】 プロテアーゼ生産能を有する微生物が、
20%脱脂粉乳を基質として25〜40℃で2日間培養
したとき、グルタミン酸を資化する分を差し引いて、少
なくともタンパク質に対して0.5重量%以上のグルタ
ミン酸を遊離するものである請求項1又は2記載の製造
法。
3. A microorganism having protease-producing ability,
2. The method of claim 1, wherein when culturing at 25 to 40 ° C. for 2 days using 20% nonfat dry milk as a substrate, at least 0.5% by weight or more of glutamic acid with respect to protein is released by subtracting the amount that assimilates glutamic acid. Or the production method according to 2.
【請求項4】 グルタミン酸デカルボキシラーゼ生産能
を有する微生物が、グルタミン酸又はその塩を1000
mg/100mL添加した培地において25〜40℃で培養
したとき、γ−アミノ酪酸を600mg/100mL以上産
生する能力を持つものである請求項1、2又は3記載の
製造法。
4. A microorganism capable of producing glutamic acid decarboxylase, wherein glutamic acid or a salt thereof is dissolved in 1000
4. The method according to claim 1, which has the ability to produce γ-aminobutyric acid in an amount of 600 mg / 100 mL or more when cultured at 25 to 40 ° C. in a medium supplemented with mg / 100 mL.
【請求項5】 飲食品が発酵乳飲食品である請求項1〜
4のいずれか1項記載の製造法。
5. The food or drink is a fermented milk food or drink.
5. The production method according to any one of 4.
【請求項6】 請求項1〜5のいずれか1項記載の方法
により得られるγ−アミノ酪酸含有飲食品。
6. A γ-aminobutyric acid-containing food or drink obtained by the method according to any one of claims 1 to 5.
JP11483199A 1998-04-27 1999-04-22 Method for producing GABA-containing food and drink Expired - Fee Related JP3172150B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11483199A JP3172150B2 (en) 1998-04-27 1999-04-22 Method for producing GABA-containing food and drink

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10-116711 1998-04-27
JP11671198 1998-04-27
JP11483199A JP3172150B2 (en) 1998-04-27 1999-04-22 Method for producing GABA-containing food and drink

Publications (2)

Publication Number Publication Date
JP2000014356A true JP2000014356A (en) 2000-01-18
JP3172150B2 JP3172150B2 (en) 2001-06-04

Family

ID=26453494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11483199A Expired - Fee Related JP3172150B2 (en) 1998-04-27 1999-04-22 Method for producing GABA-containing food and drink

Country Status (1)

Country Link
JP (1) JP3172150B2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032441A1 (en) * 2000-10-13 2002-04-25 Kabushiki Kaisha Yakult Honsha Bone metabolism improving agent
JP2002281922A (en) * 2001-03-29 2002-10-02 Hayashibara Biochem Lab Inc METHOD FOR PRODUCING FOOD MATERIAL WITH INCREASED gamma- AMINOBUTYRIC ACID CONTENT
JP2004269361A (en) * 2003-03-04 2004-09-30 Pharmafoods Kenkyusho:Kk Growth hormone sectretomotory composition
WO2005038008A1 (en) * 2003-10-16 2005-04-28 Barumin Co., Ltd. A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria
WO2005096841A1 (en) * 2004-04-07 2005-10-20 Symrise Gmbh & Co. Kg Use of ϝ-aminobutanoic acid for masking or reducing an unpleasant flavor impression, and preparations containing ϝ-aminobutanoic acid
JP2006306848A (en) * 2005-03-28 2006-11-09 Taisho Pharmaceut Co Ltd Copper compound-incorporated composition for liquid preparation for internal use
JP2007020527A (en) * 2005-07-21 2007-02-01 Fuji Oil Co Ltd METHOD FOR PRODUCING FOOD PLENTIFULLY CONTAINING gamma-AMINOBUTYRIC ACID (GABA) AND gamma-AMINOBUTYRIC ACID-PRODUCING BACTERIUM: LACTOBACILLUS CURVATUS KM14 STRAIN
KR100683948B1 (en) 2005-12-27 2007-02-16 씨제이 주식회사 MEDIUM COMPRISING GOCHUJANG-FERMENTATION OR SOYBEAN SAUCE AND PRODUCTION METHOD OF gamma;-AMINOBUTYRIC ACID
EP1759594A1 (en) * 2005-08-31 2007-03-07 Kagome Co., Ltd Production method of food and beverage products with high content of gamma-aminobutyric acid and food and beverage products with high content of gamma-aminobutyric acid
JP2007236271A (en) * 2006-03-08 2007-09-20 Unitika Ltd METHOD FOR PRODUCING COMPOSITION RICHLY CONTAINING gamma-AMINOBUTYRIC ACID
JP4615820B2 (en) * 2000-06-02 2011-01-19 池田食研株式会社 Method for producing fermented food with high content of γ-aminobutyric acid and free amino acid
KR101106668B1 (en) * 2009-04-27 2012-01-18 (주)바이오벤 The preparing method for natural GABA using serial fermentation of plant originated lactic acid bacteria with GABA-producing ability and protease-producing ability
JP2013116086A (en) * 2011-12-05 2013-06-13 Taiyo Corp Germinated soybean fermented composition
CN110301480A (en) * 2018-03-20 2019-10-08 内蒙古蒙牛乳业(集团)股份有限公司 Milk-contained drink and preparation method thereof
JP2021058093A (en) * 2019-10-03 2021-04-15 株式会社ミル総本社 Method of producing lactic acid fermented food

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6014238B1 (en) * 2015-12-25 2016-10-25 利仁 曽根 Finger position print knob fan

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4615820B2 (en) * 2000-06-02 2011-01-19 池田食研株式会社 Method for producing fermented food with high content of γ-aminobutyric acid and free amino acid
WO2002032441A1 (en) * 2000-10-13 2002-04-25 Kabushiki Kaisha Yakult Honsha Bone metabolism improving agent
US7754255B2 (en) 2000-10-13 2010-07-13 Kabushiki Kaisha Yakult Honsha Bone metabolism improving agent
JP2002281922A (en) * 2001-03-29 2002-10-02 Hayashibara Biochem Lab Inc METHOD FOR PRODUCING FOOD MATERIAL WITH INCREASED gamma- AMINOBUTYRIC ACID CONTENT
JP2004269361A (en) * 2003-03-04 2004-09-30 Pharmafoods Kenkyusho:Kk Growth hormone sectretomotory composition
JP4596304B2 (en) * 2003-03-04 2010-12-08 株式会社ファーマフーズ Growth hormone secretion promoting composition
WO2005038008A1 (en) * 2003-10-16 2005-04-28 Barumin Co., Ltd. A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria
WO2005096841A1 (en) * 2004-04-07 2005-10-20 Symrise Gmbh & Co. Kg Use of ϝ-aminobutanoic acid for masking or reducing an unpleasant flavor impression, and preparations containing ϝ-aminobutanoic acid
JP2006306848A (en) * 2005-03-28 2006-11-09 Taisho Pharmaceut Co Ltd Copper compound-incorporated composition for liquid preparation for internal use
JP2007020527A (en) * 2005-07-21 2007-02-01 Fuji Oil Co Ltd METHOD FOR PRODUCING FOOD PLENTIFULLY CONTAINING gamma-AMINOBUTYRIC ACID (GABA) AND gamma-AMINOBUTYRIC ACID-PRODUCING BACTERIUM: LACTOBACILLUS CURVATUS KM14 STRAIN
JP4618033B2 (en) * 2005-07-21 2011-01-26 不二製油株式会社 Method for producing food rich in γ-aminobutyric acid and γ-aminobutyric acid producing bacterium Lactobacillus carbatus KM14
EP1759594A1 (en) * 2005-08-31 2007-03-07 Kagome Co., Ltd Production method of food and beverage products with high content of gamma-aminobutyric acid and food and beverage products with high content of gamma-aminobutyric acid
US7923046B2 (en) 2005-08-31 2011-04-12 Kagome Co., Ltd. Production method of food and beverage products with high content of γ-aminobutyric acid and food and beverage products with high content of γ-aminobutyric acid
WO2007075011A1 (en) * 2005-12-27 2007-07-05 Cj Cheiljedang Corporation Medium comprising fermented korean hot pepper paste or soybean sauce and production method of gamma-aminobutyric acid
KR100683948B1 (en) 2005-12-27 2007-02-16 씨제이 주식회사 MEDIUM COMPRISING GOCHUJANG-FERMENTATION OR SOYBEAN SAUCE AND PRODUCTION METHOD OF gamma;-AMINOBUTYRIC ACID
JP2007236271A (en) * 2006-03-08 2007-09-20 Unitika Ltd METHOD FOR PRODUCING COMPOSITION RICHLY CONTAINING gamma-AMINOBUTYRIC ACID
JP4628978B2 (en) * 2006-03-08 2011-02-09 ユニチカ株式会社 Method for producing composition with high content of γ-aminobutyric acid
KR101106668B1 (en) * 2009-04-27 2012-01-18 (주)바이오벤 The preparing method for natural GABA using serial fermentation of plant originated lactic acid bacteria with GABA-producing ability and protease-producing ability
JP2013116086A (en) * 2011-12-05 2013-06-13 Taiyo Corp Germinated soybean fermented composition
CN110301480A (en) * 2018-03-20 2019-10-08 内蒙古蒙牛乳业(集团)股份有限公司 Milk-contained drink and preparation method thereof
JP2021058093A (en) * 2019-10-03 2021-04-15 株式会社ミル総本社 Method of producing lactic acid fermented food
JP7312447B2 (en) 2019-10-03 2023-07-21 株式会社ミル総本社 Method for producing lactic acid fermented food

Also Published As

Publication number Publication date
JP3172150B2 (en) 2001-06-04

Similar Documents

Publication Publication Date Title
Farnworth et al. Growth of probiotic bacteria and bifidobacteria in a soy yogurt formulation
Lourens-Hattingh et al. Yogurt as probiotic carrier food
US4187321A (en) Method for producing foods and drinks containing bifidobacteria
JP3172150B2 (en) Method for producing GABA-containing food and drink
US5230912A (en) Method of preparing milk-fermented food
EP1893033B1 (en) Method for preparing a dairy analogue
JP4340388B2 (en) Preparation of food by fermenting soy milk with Streptococcus thermophilus
RU2008105399A (en) FERMENTED FOOD PRODUCTS CONTAINING PROBIOTIC STRAINS AND THE METHOD FOR PRODUCING THEM
CA2811390C (en) Method of production of fermented, pro-healthy, cereal beverages
JP2002300862A (en) METHOD FOR PRODUCING gamma-AMINOBUTYRIC ACID-CONTAINING NATURAL FOOD MATERIAL
KR100882278B1 (en) Soy yogurt fermented with kimchi lactic acid bacteria and production method
EP3328208B1 (en) Methods for the preparation of fermented products comprising bifidobacteria
JP3888811B2 (en) Method for producing fermented milk containing GABA
Yeboah et al. A review of fermentation and the nutritional requirements for effective growth media for lactic acid bacteria
CN116790450B (en) Fermenting bacteria agent for improving viable bacteria amount of probiotics, N-15 fermented milk and preparation method
JP7312447B2 (en) Method for producing lactic acid fermented food
CA2811389C (en) Method of production of fermented, pro-healthy fruit beverages
JP2000032911A (en) Whey beverage and its production
JP4307026B2 (en) Lactic acid bacteria growth promoter and process for producing the same
JP2871379B2 (en) How to improve the flavor and color of soy products
Shah et al. Recent advances in biosynthesis of vitamin and enzyme from food grade bacteria
Aspri Donkey milk microbiota: isolation and characterization for potential applications
JPS6053580B2 (en) Method for producing bifidobacteria-fermented milk
JPS6359850A (en) Production of yogurt-like fermented food
JPS6359837A (en) Production of yogurt-like fermented food

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
R151 Written notification of patent or utility model registration

Ref document number: 3172150

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080323

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090323

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090323

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100323

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110323

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120323

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120323

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130323

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140323

Year of fee payment: 13

LAPS Cancellation because of no payment of annual fees